shutterstock_1650524983_sundry_photography
Sundry Photography / Shutterstock.com
21 February 2020AmericasSarah Morgan

Illumina asks court to halt BGI’s sequencer distribution

Genetic sequencing company Illumina is seeking a preliminary injunction to stop its China-based rival BGI from distributing DNA sequencers in the US.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
4 October 2019   A US subsidiary of Chinese genome sequencing company BGI has filed a patent infringement counterclaim against Illumina.
Americas
2 July 2019   Genetic sequencing company Illumina has continued its campaign of filing patent lawsuits against rival BGI, with the filing of three additional infringement suits.
Americas
18 June 2020   Genetic sequencing company Illumina has obtained a preliminary injunction against its China-based rival BGI.

More on this story

Big Pharma
4 October 2019   A US subsidiary of Chinese genome sequencing company BGI has filed a patent infringement counterclaim against Illumina.
Americas
2 July 2019   Genetic sequencing company Illumina has continued its campaign of filing patent lawsuits against rival BGI, with the filing of three additional infringement suits.
Americas
18 June 2020   Genetic sequencing company Illumina has obtained a preliminary injunction against its China-based rival BGI.

More on this story

Big Pharma
4 October 2019   A US subsidiary of Chinese genome sequencing company BGI has filed a patent infringement counterclaim against Illumina.
Americas
2 July 2019   Genetic sequencing company Illumina has continued its campaign of filing patent lawsuits against rival BGI, with the filing of three additional infringement suits.
Americas
18 June 2020   Genetic sequencing company Illumina has obtained a preliminary injunction against its China-based rival BGI.